
In this All-Member webinar for May 2016, CAC2 welcomed Dr. Cesare Spadoni, Chairman and Co-Founder of Accelerating Paediatric Oncology Drug Development.
Parents and non-profit entities can play a strong role in driving drug development and thus accelerate the availability of more innovative drugs for children with cancer. But to do, so they must adopt new operating models and collaborate more effectively with other stakeholders.
Categories
- Blog Posts (124)
- Explainer Post (13)
- Guest Blogs (28)
- Member Blogs (44)
- Survivorship Matters Blog (9)
- CAC2 News (24)
- Collaborative Achievements (15)
- Community News (284)
- In Memoriam (2)
- News Digest (231)
- Webinars (68)
Tags
Advocacy (58)
Annual Summit (7)
Appropriations (1)
Awareness (26)
AYA (2)
Bereavement (1)
Best Practices (14)
Biorepositories (2)
CAC2 News (8)
CAC2 Projects (11)
Call to Action (27)
Call to Action Prevention (1)
Care Giving (1)
Clinical Trials (11)
COG (2)
Collaboration (14)
Data (16)
Delayed Diagnosis (2)
Digest (12)
Drug Development (18)
Drug Development collaboration (1)
Drug Shortages (3)
Ethics (1)
Family Support (17)
FDA (2)
Funding Research (9)
Genomics (6)
Global News (4)
Industry Perspective (5)
Member Access (12)
NCI (3)
Nutrition (2)
Post-Mortem Tissue Donation (1)
Prevention (3)
Psychosocial Support (6)
Rare and Ultra Rare Cancer (1)
Regulations (3)
Research (44)
Research Advocacy (3)
Research Data (2)
Research Tissue Donation (1)
Social Work (1)
state advocacy (1)
Survivorship (30)
Venture Philanthropy (3)
Recent Posts
- CAC2 Childhood Cancer Community News Digest (June 2-8)
- CAC2 Webinar–“Beyond the Signature: Demystifying Informed Consent in Childhood Cancer”
- CAC2 Childhood Cancer Community News Digest (May 26-June 1)
- Guest Blog–SAVE MEDICAID (SENATE): Materials to Share with your Communities
- CAC2 Childhood Cancer Community News Digest (May 19-25)